A multicentre randomized controlled trial of recombinant interferon-alpha-2a in the treatment of patients with chronic hepatitis C.
Komatsu M, Ono T, Nakajima K, Toyoshima I, Chiba M, Masamune O, Ohkubo S, Yoshida T, Yagisawa H, Komatsu K, Wakamatsu H, Yamada N, Watanabe H, Mukojima T, Goto M.
Komatsu M, et al. Among authors: chiba m.
Can J Gastroenterol. 1997 Oct;11(7):579-82. doi: 10.1155/1997/454395.
Can J Gastroenterol. 1997.
PMID: 9395758
Clinical Trial.